A Vision of Hope Media. Everyone has something to recover from. Books, curriculum, recovery, reentry, media.
A Vision of Hope Media. Everyone Has Something to Recover From

Insights · Series

Drug Legalization Series

This series argues that drug policy should be written for outcomes — not fear, stigma, or moral panic. Each part builds on the last — from why punishment fails, to what regulation actually looks like, to pilot programs, case studies, and the reentry window we keep wasting.

Featured pillar

All insights All series

  1. Part 1.5

    Drug Legalization Series Part 1.5: Legalization vs Decriminalization vs Regulation: Drug Policy Explained

    Legalization isn't one policy. This post explains legalization vs decriminalization vs regulation — and what strict regulation delivers.

  2. Part 2

    Pillar guide

    Drug Legalization Series Part 2: How Drug Criminalization Creates a Permanent Underclass

    Drug felony consequences go far beyond court — employment and housing barriers, ruined credit, and traps that follow people long after release.

  3. Part 3

    Drug Legalization Series Part 3: The Hidden Sentence

    Drug felony conviction: voting rights, gun rights, and the permanent sentence rarely discussed. Part 3 in the drug legalization series.

  4. Part 4

    Drug Legalization Series Part 4: What Drug Legalization and Regulation Actually Buys Us

    Legalization and regulation isn't endorsement — a regulated supply with testing, labeling, fentanyl strips, and accountability prohibition can't deliver.

  5. Part 5

    Drug Legalization Series Part 5: How Illegal Drug Markets Power Gangs and Cartels

    Drug prohibition violence is predictable — illegal markets fuel gangs, cartels, and violence. How prohibition creates the chaos it claims to stop.

  6. Part 6

    Drug Legalization Series Part 6: Tusi (Pink Cocaine), Xylazine, and THC Analogues: Why Enforcement Can’t Keep Up

    Tusi, xylazine, medetomidine, nitazenes, and THC analogues prove enforcement can't keep up. Regulation creates testing, labeling, and accountability.

  7. Part 7

    Drug Legalization Series Part 7: Recovery Lockbox: Fund Addiction Treatment Without Raising Taxes

    A recovery lockbox captures enforcement savings and regulated-market revenue to fund MOUD, housing, and reentry — using FY 2025 budget realities.

  8. Part 8

    Drug Legalization Series Part 8: Fear Is Not a Policy: The Known Failure vs the Imagined Risk

    Part 8 explores fear-based drug policy, Oregon's Measure 110 results, and what effective drug policy would require in the legalization series.

  9. Part 9

    Drug Legalization Series Part 9: What Regulation Would Actually Look Like

    Risk-based drug regulation in practice: supply control, age and potency limits, licensing, taxation, enforcement priorities, and recovery infrastructure.

  10. Part 10

    Drug Legalization Series Part 10: With Drug Legalization, Accountability Still Exists

    Part 10 explores drug legalization accountability — what gets enforced when use isn't a crime, and how a regulated market protects the public.

  11. Part 11

    Drug Legalization Series Part 11: Prevention That Isn’t Propaganda

    Evidence-based drug prevention beats scare tactics — what reduces youth use, why fear-based education fails, and how prevention fits regulation.

  12. Part 12

    Drug Legalization Series Part 12: The Reentry Window We Keep Wasting

    Prison release overdose risk peaks in days and weeks after release. Which programs actually cut overdose, recidivism, and instability.

  13. Part 13

    Drug Legalization Series Part 13: Mental Health, Housing, and Despair

    Part 13 explores drug addiction and homelessness, mental illness, and housing-first recovery in the drug legalization and regulation series.

  14. Part 14

    Drug Legalization Series Part 14: A Regulated Pharmacy Model for High-Risk Substances

    A regulated pharmacy model for high-risk substances could replace street chaos with standards, cut overdose risk, and connect people to treatment fast.

  15. Part 15

    Drug Legalization Series Part 15: Arguments Against Drug Legalization: The Hard Objections, Answered Directly

    The strongest arguments against drug legalization deserve direct answers — pros and cons, youth access, public safety, and whether use rises.

  16. Part 16

    Drug Legalization Series Part 16: How to Run a Drug Legalization Pilot Program Without Betting the Farm

    Part 16: a drug legalization pilot framework — risk-based regulation, measured outcomes, diversion control, privacy, and results-based funding.

  17. Part 17

    Drug Legalization Series Part 17: Case Studies Without Cherry-Picking — What Worked, What Failed, and Why

    Part 17 reviews drug decriminalization case studies across the U.S. and abroad to show what worked, what failed, and why — without cherry-picking.

  18. Part 18

    Pillar guide

    Drug Legalization Series Part 18: Public Health, Not Moral Panic — Building a Public Health Drug Policy That Actually Reduces Harm

    Part 18 makes the case for public health drug policy that replaces moral panic with overdose prevention, harm reduction, and treatment on demand.

  19. Part 19

    Drug Legalization Series Part 19: This Is Already Being Administered — The Myth That Regulation Is Too Complex to Run

    Part 19 argues regulation is already administered across health, safety, and controlled-substance systems — and how that capacity can scale responsibly.

  20. Part 20

    Drug Legalization Series Part 20: Urgency Without Panic — Why This Can't Wait Another Decade

    Part 20 explains why an overdose prevention strategy can't wait another decade, and lays out urgent, measurable steps that reduce death without panic.

  21. Part 21

    Drug Legalization Series Part 21: Drug Legalization Is Bipartisan: Political Reality, Not Political Fantasy

    Part 21 explains why bipartisan drug policy reform is viable now and why regulated legalization is a public health and safety upgrade, not ideology.

  22. Part 22

    Drug Legalization Series Part 22: Public Buy-In Is Built, Not Waited For: How Public Opinion Actually Shifts on Uncomfortable Drug Policy

    How leaders build public support for drug policy that feels uncomfortable first — and why public perception shapes what lawmakers pass and fund.

  23. Part 23

    Drug Legalization Series Part 23: What Failure Looks Like If We Don't Change: Projecting the Status Quo Forward

    Part 23 models drug overdose death projections under today's laws, showing what failure may look like if we keep the status quo.

  24. Part 24

    Drug Legalization Series Part 24: The Ethical Case for Regulation — What We Owe People We Know Will Use Drugs

    Part 24 on drug legalization ethics: we owe regulation that cuts preventable death instead of outsourcing safety to a black market when use is inevitable.

  25. Part 25

    Drug Legalization Series Part 25: Punishing Pain or Saving Lives — The Real Choice in Drug Policy Reform

    Part 25 reframes drug policy as punishing pain or saving lives: public health, overdose prevention, treatment on demand, and risk-based regulation.